Opinion article
Biosimilars or Follow-on Biologics in Dermatology
Biosimilares o biosecuelas en Dermatología
L. Puig
Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Universidad Autónoma de Barcelona, Barcelona, Spain
Read
6341
Timeswas read the article
2990
Total PDF
3351
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 56 | 29 | 85 |
| 2025 5 | 81 | 30 | 111 |
| 2025 4 | 71 | 19 | 90 |
| 2025 3 | 0 | 3 | 3 |
| 2025 2 | 0 | 2 | 2 |
| 2025 1 | 80 | 26 | 106 |
| 2024 12 | 68 | 25 | 93 |
| 2024 11 | 71 | 53 | 124 |
| 2024 10 | 71 | 46 | 117 |
| 2024 9 | 73 | 23 | 96 |
| 2024 8 | 119 | 73 | 192 |
| 2024 7 | 72 | 64 | 136 |
| 2024 6 | 79 | 34 | 113 |
| 2024 5 | 85 | 33 | 118 |
| 2024 4 | 74 | 31 | 105 |
| 2024 3 | 62 | 31 | 93 |
| 2024 2 | 78 | 36 | 114 |
| 2024 1 | 57 | 34 | 91 |
| 2023 12 | 40 | 33 | 73 |
| 2023 11 | 35 | 27 | 62 |
| 2023 10 | 38 | 35 | 73 |
| 2023 9 | 29 | 30 | 59 |
| 2023 8 | 37 | 18 | 55 |
| 2023 7 | 33 | 285 | 318 |
| 2023 6 | 30 | 26 | 56 |
| 2023 5 | 43 | 29 | 72 |
| 2023 4 | 34 | 25 | 59 |
| 2023 3 | 40 | 35 | 75 |
| 2023 2 | 39 | 21 | 60 |
| 2023 1 | 27 | 33 | 60 |
| 2022 12 | 28 | 48 | 76 |
| 2022 11 | 20 | 32 | 52 |
| 2022 10 | 16 | 21 | 37 |
| 2022 9 | 20 | 25 | 45 |
| 2022 8 | 16 | 36 | 52 |
| 2022 7 | 24 | 34 | 58 |
| 2022 6 | 21 | 17 | 38 |
| 2022 5 | 23 | 46 | 69 |
| 2022 4 | 20 | 32 | 52 |
| 2022 3 | 26 | 44 | 70 |
| 2022 2 | 19 | 21 | 40 |
| 2022 1 | 18 | 40 | 58 |
| 2021 12 | 19 | 35 | 54 |
| 2021 11 | 20 | 46 | 66 |
| 2021 10 | 25 | 46 | 71 |
| 2021 9 | 15 | 36 | 51 |
| 2021 8 | 17 | 30 | 47 |
| 2021 7 | 11 | 32 | 43 |
| 2021 6 | 15 | 38 | 53 |
| 2021 5 | 11 | 48 | 59 |
| 2021 4 | 38 | 60 | 98 |
| 2021 3 | 29 | 26 | 55 |
| 2021 2 | 43 | 37 | 80 |
| 2021 1 | 24 | 11 | 35 |
| 2020 12 | 15 | 11 | 26 |
| 2020 11 | 16 | 21 | 37 |
| 2020 10 | 16 | 10 | 26 |
| 2020 9 | 16 | 15 | 31 |
| 2020 8 | 17 | 22 | 39 |
| 2020 7 | 12 | 13 | 25 |
| 2020 6 | 14 | 25 | 39 |
| 2020 5 | 17 | 15 | 32 |
| 2020 4 | 18 | 12 | 30 |
| 2020 3 | 18 | 32 | 50 |
| 2020 2 | 0 | 8 | 8 |
| 2020 1 | 0 | 10 | 10 |
| 2019 12 | 0 | 7 | 7 |
| 2019 11 | 0 | 4 | 4 |
| 2019 10 | 0 | 2 | 2 |
| 2019 9 | 0 | 3 | 3 |
| 2019 8 | 0 | 1 | 1 |
| 2019 7 | 0 | 17 | 17 |
| 2019 6 | 0 | 19 | 19 |
| 2019 5 | 0 | 34 | 34 |
| 2019 3 | 0 | 6 | 6 |
| 2019 2 | 0 | 3 | 3 |
| 2018 3 | 1 | 1 | 2 |
| 2018 2 | 12 | 3 | 15 |
| 2018 1 | 12 | 5 | 17 |
| 2017 12 | 10 | 7 | 17 |
| 2017 11 | 9 | 2 | 11 |
| 2017 10 | 12 | 5 | 17 |
| 2017 9 | 9 | 4 | 13 |
| 2017 8 | 13 | 9 | 22 |
| 2017 7 | 7 | 3 | 10 |
| 2017 6 | 7 | 5 | 12 |
| 2017 5 | 10 | 6 | 16 |
| 2017 4 | 11 | 4 | 15 |
| 2017 3 | 8 | 9 | 17 |
| 2017 2 | 11 | 10 | 21 |
| 2017 1 | 7 | 5 | 12 |
| 2016 12 | 20 | 8 | 28 |
| 2016 11 | 24 | 5 | 29 |
| 2016 10 | 13 | 7 | 20 |
| 2016 9 | 16 | 9 | 25 |
| 2016 8 | 14 | 4 | 18 |
| 2016 7 | 19 | 8 | 27 |
| 2016 6 | 6 | 8 | 14 |
| 2016 5 | 6 | 9 | 15 |
| 2016 4 | 4 | 6 | 10 |
| 2016 3 | 5 | 7 | 12 |
| 2016 2 | 5 | 8 | 13 |
| 2016 1 | 9 | 10 | 19 |
| 2015 12 | 7 | 4 | 11 |
| 2015 11 | 6 | 8 | 14 |
| 2015 10 | 4 | 9 | 13 |
| 2015 9 | 11 | 7 | 18 |
| 2015 8 | 13 | 2 | 15 |
| 2015 7 | 21 | 4 | 25 |
| 2015 6 | 21 | 11 | 32 |
| 2015 5 | 38 | 14 | 52 |
| 2015 4 | 29 | 12 | 41 |
| 2015 3 | 23 | 19 | 42 |
| 2015 2 | 21 | 13 | 34 |
| 2015 1 | 18 | 11 | 29 |
| 2014 12 | 22 | 7 | 29 |
| 2014 11 | 15 | 15 | 30 |
| 2014 10 | 24 | 13 | 37 |
| 2014 9 | 26 | 17 | 43 |
| 2014 8 | 28 | 16 | 44 |
| 2014 7 | 29 | 13 | 42 |
| 2014 6 | 34 | 8 | 42 |
| 2014 5 | 37 | 12 | 49 |
| 2014 4 | 31 | 7 | 38 |
| 2014 3 | 48 | 21 | 69 |
| 2014 2 | 29 | 21 | 50 |
| 2014 1 | 29 | 12 | 41 |
| 2013 12 | 32 | 18 | 50 |
| 2013 11 | 19 | 18 | 37 |
| 2013 10 | 23 | 14 | 37 |
| 2013 9 | 27 | 19 | 46 |
| 2013 8 | 18 | 17 | 35 |
| 2013 7 | 15 | 19 | 34 |
| 2013 6 | 14 | 30 | 44 |
| 2013 5 | 18 | 22 | 40 |
| 2013 4 | 11 | 24 | 35 |
| 2013 3 | 18 | 31 | 49 |
| 2013 2 | 13 | 15 | 28 |
Show all
